We have an update on a post we published late last month. We reported on March 31 that Tissue Engineering had retracted a paper by Xing Wei, of the, National Engineering Research Center of Genetic Medicine at Jinan University, in Guangzhou, China, because of image manipulation. The retraction notice for that paper, “Use of Decellularized … Continue reading The tale of the secret publishing ban
Jasti Rao, who once earned $700,000 a year at the University of Illinois College of Medicine at Peoria and was named the first “Peorian of the Year” before a misconduct investigation put an end to his time there, has now lost eight papers. Rao’s case is among the more colorful that we’ve covered. A highly-regarded … Continue reading Former star cancer researcher who sued his university for discrimination notches eighth retraction
In the market for an admirably clear and concise retraction notice? Look no further! A researcher in China has lost one — well, maybe two, more on that in a moment — 2015 articles for falsification of data and other misconduct. And one of the journals he tried to dupe is having none of it. … Continue reading A tale of one exceedingly clear retraction notice, and two nonexistent ones
Researchers in Singapore have lost a 2011 paper in Gene Therapy after an institutional investigation found that some of their data had been fabricated by a PhD student on the project. Most of the authors were affiliated with the Institute of Bioengineering and Nanotechnology, a unit of the Agency for Science, Technology and Research (A*STAR). … Continue reading Researcher loses PhD after investigation finds he faked data
After a 20-month investigation, Taiwan’s leading science institution has hit a former star cancer researcher with a 10-year ban for research misconduct. Academia Sinica (AS) said its inquiry found that Ching-shih Chen, formerly a distinguished research fellow at the center, was guilty of fabricating or falsifying data in several of the nearly two dozen papers … Continue reading Researcher formerly of OSU and Taiwan’s Academia Sinica gets 10-year ban
More than five years after Nature retracted two highly suspect papers about what had been described as a major breakthrough in stem cell research, another journal has pulled a paper about the work. The scandal over so-called STAP stem cells took down more than just a few articles. The case centered on Haruko Obokata, a … Continue reading Fourth retraction for Haruko Obokata, focus of STAP cell scandal, after Harvard investigation
Citing a misconduct investigation, the journal Stem Cells has retracted a 2009 article coauthored by a researcher whose work has been under suspicion for roughly five years. The paper was titled “Cell adhesion and spreading affect adipogenesis from embryonic stem cells: the role of calreticulin.” The retraction notice, which is behind a paywall, states:
A group of dentistry researchers in Japan, whose work on stem cells has been the subject of an institutional investigation, have now lost two papers in PLOS ONE for image problems. The authors, from Aichi Gakuin University in Nagoya, were led by Makio Mogi, a medicinal biochemist at the school. Mogi asked for at least … Continue reading Stem cell researchers have papers retracted for image manipulation
Piero Anversa, a former star researcher at Harvard Medical School who left the institution under a cloud, is up to 18 retractions. But that’s barely half of the 31 papers by Anversa’s group that Harvard has requested journals pull over concerns about the integrity of the findings. The two articles, published in the Proceedings of … Continue reading Drip, drip: Former Harvard stem cell researcher up to 18 retractions
Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured a paper that used a mouse that doesn’t exist; the … Continue reading Weekend reads: Retract papers, win major awards; “citation doping;” authorship abuse